What is QMB?
QMB specializes in regulatory intelligence for the MedTech industry, utilizing proprietary AI-driven innovation to enhance compliance and expedite FDA submissions. Their flagship platform, QualiVerse, serves as a critical infrastructure component for life sciences companies, automating documentation and streamlining the product development lifecycle. By transforming traditional regulatory hurdles into strategic advantages, QMB enables innovators to maintain operational excellence while adhering to rigorous global standards. The company's unique value proposition lies in its dual-pronged approach: providing sophisticated software tools alongside expert regulatory advisory services, ensuring that clients achieve long-term compliance success in a volatile market environment.
How much funding has QMB raised?
QMB has raised a total of $2M across 1 funding round:
Seed
$2M
Seed (2025): $2M with participation from The Boston Foundation and CEI Ventures
Key Investors in QMB
The Boston Foundation
A community foundation that collaborates with donors to foster regional prosperity and address systemic inequities through data-driven grantmaking and civic leadership.
CEI Ventures
A socially responsible venture capital firm focused on financing growth-oriented businesses that prioritize fair workplace practices and long-term economic advancement.
What's next for QMB?
With this major enterprise-level funding, QMB is set to scale its QualiVerse platform to meet the growing demands of global MedTech innovators. The strategic roadmap includes expanding the AI capabilities of their documentation engine to further reduce time-to-market for complex medical devices. Furthermore, the company intends to deepen its advisory services, providing a more comprehensive suite of quality management support. As QMB continues to refine its regulatory intelligence framework, the focus will remain on maintaining a competitive edge through technological superiority and deep domain expertise, ultimately setting a new standard for efficiency in the life sciences regulatory sector.
See full QMB company page
